Five Tips for Maximizing Your Patient Panels
"Keep the sessions on topic. I get it, patients have an insurmountable amount to deal with, and while it’s important to be empathetic, it’s also important to stay on task and n
Beyond Placebos: The Promise and Limitations of Synthetic Control Arms
Synthetic control arms offer so many benefits. No one gets a placebo and the study arms are near-perfectly matched, providing a window into the path not taken for every participant
Three Pillars for Patient Engagement: Understand, Reflect, and Personalize
Below, we share three core pillars for modern, authentic patient engagement––understanding your audience, reflecting their needs via patient-centric resources, and personalizin
Oncolytic Viruses: An Overlooked Ally in the Fight Against Cancer
Oncolytic viruses are a compelling cancer treatment strategy that is rapidly gaining attention for its elegant and powerful design. However, only four oncolytic viruses have gained
What We’re Watching for at J.P. Morgan Week 2024
The J.P. Morgan Healthcare Conference and associated events in January remain a bellwether for the economic health of the life science, biopharma, and medical sectors as hundreds o
Strategic Communications for Pre-Commercial Biopharma Organizations
Recent economic stressors are challenging the biopharma R&D pipeline, forcing many companies to make tough strategic decisions and unprecedented cuts to R&D programs. While we canâ
Our Guidelines to Gain Strategic Marketing Value Through AI and Emerging Technologies
AI is changing the way the world works. From ChatGPT to Google's new Search Labs, the power that AI has to enhance our work is powerful, but that doesn't mean it can ever truly rep
The Elimination of Third-Party Cookies and New Consumer Privacy Policies
In this blog post, we discuss the future elimination of third-party cookies, and what the future looks like for web privacy.